NCT04630015
- Conditions
- COVID-19, COVID-19 Infection, Coronaviridae Infections, +17 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Clinical trial condition
Hematopoietic and Lymphoid Cell Neoplasm
Explore clinical trials studying Hematopoietic and Lymphoid Cell Neoplasm. Study availability and eligibility vary by location and protocol.
160 public trials
28 recruiting studies
Hematopoietic and Lymphoid Cell Neoplasm trial results
Completed
New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality
NCT03980535
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04759183
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT02686411
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04870320
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
NCT05060328
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04652505
- Conditions
- COVID-19, COVID-19 Infection, Coronaviridae Infections, +17 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04439240
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +22 more
- Locations
-
- ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States
NCT04439214
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Blood Protein Disorders, +23 more
- Locations
-
- ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States
Completed
Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
NCT02805075
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States